STUDY QUESTION: Is the negative correlation between the numbers of 2-5 and 6-9 mm follicles influenced by ovarian and/or metabolic parameter(s) in young control women and in patients with polycystic ovarian syndrome (PCOS)?
Introduction
Polycystic ovarian syndrome (PCOS) is a common endocrine and metabolic disorder affecting 5-10% of women worldwide (Norman et al., 2007) . A 'follicular arrest' is one of the abnormalities described in this syndrome. It is characterized by an excess of 2-5 mm antral follicles, a lack of maturation to 6-9 mm antral follicles and a default of selection of one follicle leading to oligo-anovulation and menstrual irregularity. Hence, a strong and negative correlation between 2-5 and 6-9 mm follicles is expected in this population.
Based on ultrasound (U/S) data, two previous reports described a direct negative correlation between the number of small antral follicles (2-5 mm) and large antral follicle (6-9 mm) during the early follicular phase (cycle Days 2-5) in normal women (Haadsma et al., 2007; Bentzen et al., 2013) . This phenomenon was attributed to ovarian ageing with higher proportion of large antral follicles along with increasing age whereas proportion of small follicles decreases (Hansen et al., 2008) . This phenomenon is consistent with the shortening of the follicular phase with age and the shift of intercyclic FSH rise toward the previous late luteal phase (van Zonneveld et al., 2003) . It also explains the increased rate of multi-ovulation in older women resulting in a higher incidence of dizygotic twinning (Bortolus et al., 1999) .
However, we have previously reported that such a negative relationship between these two follicle numbers was also present in younger control women as well as in women with PCOS . This suggests the presence of a physiological negative influence from the 2-5 mm follicle pool on the large antral follicles which could be exaggerated in PCOS patients, leading to the 'follicular arrest' , and which conversely decreases in older women allowing multiple ovulation.
Therefore, besides ovarian ageing, other factors could be involved in this negative influence that could be either intrinsic to the ovary or secondary to metabolic influence and/or gonadotropin regulation. anti-Müllerian hormone (AMH), mainly secreted by granulosa cells of pre-antral and small antral follicle, could be a good candidate since one of its role is the inhibition of FSH-dependent cyclic recruitment through aromatase inhibition (Dewailly et al., 2016) . In agreement with this hypothesis, serum AMH level is strongly correlated to the count of small antral follicle (2-5 mm) (Dewailly et al., 2014) but not to the 6-9 mm follicle pool .
The aims of this study were therefore the following: (i) to confirm the negative correlation between the 2-5 and 6-9 mm follicle numbers in young control patients and in women with PCOS; (ii) to determine if this negative correlation is stronger in PCOS women compared to controls; (iii) to investigate whether this inverse correlation is linked to ovarian and/or metabolic parameter(s) in both control and PCOS patients; and (iv) to search for a putative relationship between this inverse relationship and the hyperandrogenism (HA) and/or oligo-anovulation of PCOS.
Materials and Methods

Patient and control populations
Data were obtained from a database including clinical, hormonal and U/S features that were consecutively recorded between January 2009 and January 2016 in patients referred to our department in an academic hospital for HA and/or oligo-anovulation and/or infertility (n = 1237). The STROBE-statement recommendations for cross-sectional studies were followed (von Elm et al., 2007) . Patients were retrospectively included in this study according to the selection criteria described below for PCOS or control groups.
In total, 639 patients were included in the PCOS group according to a modified Rotterdam classification (Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004), i.e. presence of at least two out of the three following items: (i) HA, defined clinically as the presence of hirsutism (modified Ferriman and Gallwey score > 6) and/or biologically by serum total testosterone (TT) and/or delta-4-androstenedione (A) level >0.53 and 2.07 ng/mL, respectively (95th percentiles of controls with normal cycles ); (ii) oligo-anovulation, defined as the presence of oligomenorrhea (i.e. fewer than eight menstrual bleeds over the previous year) or amenorrhoea (i.e. no menstrual bleed over the previous 3 months); and (iii) presence of Polycystic Ovarian Morphology (PCOM) at U/S, with an ovarian area ≥ 5.5 cm 2 and/or a follicle number per ovary (FNPO) ≥ 19, according to our in-house thresholds, as previously reported (Jonard et al., 2005; Dewailly et al., 2011) . Overall, 157 non-hyperandrogenic normo-ovulatory women were included as controls. They were referred to our department for infertility due to tubal and/or sperm abnormality. None of these women had any component of the Rotterdam classification: they had regular cycles, no hyperandrogenia (HA) and normal ovaries on U/S.
The following exclusion criteria were applied to select both patients and controls for this study: age < 18 years or >35 years, presence of premature ovarian failure (FSH > 12 IU/L), hyperprolactinemia (PRL > 20 ng/mL) or non-classic 21-hydroxylase deficiency.
Patients in whom transvaginal U/S was inappropriate (virgin or those who declined) were excluded from the study, as well as those in whom no follicle was seen in either the right or the left ovary. Any patient with at least one follicle with a diameter >10 mm was excluded from the study so as not to confound the hormonal data with the presence of a dominant follicle. In all, 154 patients eligible for inclusion in either the control or the PCOS group were excluded on the basis of U/S data.
All medications known to affect metabolism (e.g. metformin) or folliculogenesis (e.g. pill) had to be stopped at least 3 months before blood tests and U/S.
Hormonal immunoassays
Blood sampling was performed in the early follicular phase (i.e. between cycle Days 2 and 5) both in patients and control women. In oligo-or amenorrhoeic patients, the menstrual period was either spontaneous or induced by the administration of didrogesterone. FSH, estradiol (E2), LH and TT levels were measured by radioimmunoassays as previously reported Pigny et al., 2006; Robin et al., 2012) . Fasting serum insulin levels (I) were measured by an immunoradiometric assay (Bi-Insulin IRMA Pasteur, Bio-Rad, Marnes la Coquette, France). The second-generation enzyme Immunoassay AMH-EIA (reference A16507) provided by Immunotech SA (a Beckman Coulter company from Marseille, France) was used according to the supplier's instructions for the assay of serum AMH for all patient in the same laboratory. A rhAMH was used as a calibration standard to build a standard curve ranging from 0 to 150 pmol/L. Intra-and inter-assay coefficients of variation were <12.3 and 14.2%, respectively. The functional sensitivity (i.e. the lowest concentration of AMH that could be measured with an inter-assay coefficient of variation <20%) was 2.50 pmol/L (Taieb et al., unpublished data; Pigny et al., 2006) .
Pelvic U/S examination
In every patient and control, U/S was performed the same day as blood sampling, between cycle Days 2 and 5, with a 5-9 MHz transvaginal transducer Voluson E8 Expert (General Electric Systems, VELIZY, France). U/S measurements were taken in real time, according to a standardized protocol allowing the 2-5 and 6-9 mm follicles to be counted separately, as previously described . All U/S were performed by four different skilled sonographers during the time course of the study. For all statistical analysis, follicle counts were averaged between the left and right ovaries.
Statistical methods
All statistical analyses were performed using SPSS software 22.0 (SPSS Inc., Chicago, IL, USA).
Standard statistical techniques
Results were expressed as medians, minimums and maximums for continuous variables and by the frequencies and percentages for categorical variables. As most of the continuous variables were not normally distributed, comparisons between two independent groups were performed using the non-parametric Mann-Whitney test. The correlations between the various parameters were expressed as Spearman's correlation coefficient (r).
Principal component analysis
A normalized principal component analysis (PCA) based on the eigenvalue decomposition of the correlation matrix was performed to investigate the relationships between numerous correlated original variables which can give redundant informations (Raychaudhuri et al., 2000) . Indeed, PCA is a multivariable statistical technique for analysing the structure of complex data sets by identifying new variables called principal components (PC) that best summarize the relationships between the original variables. Each PC is a linear combination of the original variables and they are uncorrelated.
Usually, the interpretation of the PCs is not easy because a given original variable can be correlated with several components. We then performed a 'varimax' rotation that consists of an orthogonal rotation applied to a subset of principal components. The aim of the rotation is to obtain, for each PC, strong correlations for some variables and near-zero correlations for the other variables. We considered that the correlation of a variable to any PC was strong when the absolute r value was ≥0.4.
The first PC accounts for as much of the variability in the data as possible, and each succeeding component accounts for as much of the remaining variability as possible. Only the PCs corresponding to an eigenvalue >1 were considered as significant according to the Kaiser criteria (Raychaudhuri et al., 2000) .
Ethical approval
All patients had previously given their informed consent for the use of their clinical, hormonal and U/S records. As this study was retrospective with no intervention, the opinion of the Ethics Committee about the study was not required. The Institutional Review Board of the University Hospital gave its unrestricted approval to the anonymous use of clinical, hormonal and U/S records from all patients on 19 July 2016 (reference DEC16-25).
Results
During the study period, 1237 patients were referred to our department for HA and/or oligo-anovulation and/or infertility and were examined for eligibility. According to the inclusion and exclusion criteria described in the Materials and Methods, 796 of these patients were confirmed eligible and included in the study (639 in the PCOS group and 157 in the control group). Table I shows the main clinical, hormonal and U/S features of each population. All parameters listed except glycaemia and number of 6-9 mm antral follicles were statistically significantly different between groups. As expected, PCOS women had higher BMI and waist circumference (WC). They also had higher FNPO and serum AMH level, due to the increased number of small antral follicles (2-5 mm). Tables II and III show the univariate correlations (Spearman's coefficient) between the different variables in control and PCOS groups, respectively. A negative significant correlation was found between the 2-5 and 6-9 mm follicle numbers both in controls and patients with PCOS (r = −0.386; P < 0.01 and r = −0.506; P < 0.01, respectively). Separately, both the 2-5 and 6-9 mm follicle numbers correlated significantly to many other variables, in both groups (Tables II and III) .
Since many of these variables were related to each other and redundant (e.g. BMI and WC), we used PCA rather than multivariate regression (see Materials and Methods). For that aim, we included in the analysis the variables that were significantly correlated by univariate analysis to either the 2-5 and/or 6-9 mm follicle pool(s) in controls and patients with PCOS. In both populations, PCA yielded four principal components accounting for 62.7 and 66.8% of the total variance in the control and PCOS groups, respectively.
In the control group ( Fig. 1A and Table IV) , all metabolic variables were strongly (i.e. r ≥ 0.4) correlated to the first component (PC1, 'metabolic'). PC2 reflected mainly the equilibrium between the two follicle numbers that correlated strongly and oppositely to this PC. E2 was the only remaining variable that also correlated to this PC, to a lesser degree however. This PC2 could therefore be labelled as 'follicle equilibrium'. PC3 ('ovarian ageing') was essentially built on the well-known strong inverse relationship between age and AMH (and 2-5 mm follicle number to a lesser extent). Finally, PC4 ('gonadotropin regulation'), represented the well-known physiological positive correlation between FSH and LH.
In the PCOS group, similarly to PC2 in controls, both follicle numbers strongly but inversely correlated to PC3 ('follicle equilibrium'), without any other significant correlation (Table V and Fig. 1B) . Otherwise, similarly to controls, PCA yielded 'metabolic' and 'gonadotropin regulation' PCs (PC1 and PC4, respectively, Table V and Fig. 1B) . Last, PC2 ('follicular excess') gathered the relationships between variables that are classically linked to the follicle excess of PCOS, i.e. oligo-anovulation, TT, LH, E2, AMH and 2-5 mm follicle number (Table V and Fig. 1B) .
Noteworthy, in both populations, the 6-9 mm follicle number correlated exclusively to the 'follicle equilibrium' PC (Tables IV and V) .
Discussion
Our univariate analysis confirmed the negative correlation between the two follicle numbers (2-5 and 6-9 mm) that was stronger in PCOS than in young control women, presumably because the number of 2-5 mm follicles was higher in the former than in the latter.
Interestingly, we found by PCA that this relationship was completely independent from other factors.
Indeed in both populations no parameter that correlated with the metabolic, gonadotrophin regulation, follicle ageing (in controls) or follicle excess (in PCOS) also correlated with the follicle equilibrium PC. Apart from the 2-5 and 6-9 mm follicle numbers estradiol was the only parameter to correlate with this PC and only in the control group and there relatively weakly.
In our work in 2010 (Dewailly et al., 2010) , PCA yielded both in control and PCOS group a 'metabolic' PC similar to the one found in the present study, confirming that the metabolic status has a strong influence on the whole data structure. In some studies using univariate analysis, metabolic parameters were supposed to impact negatively the follicle recruitment leading to reduced number of recruitable follicles (6-9 mm follicle pool) (Lujan et al., 2010; Leonhardt et al., 2014; Christ et al., 2015) . We found the same negative but rather weak relationships by univariate analysis in the present study but our PCA analysis showed that metabolic parameters were not directly involved in the equilibrium between follicle numbers, in both populations. Noteworthy and unlikely to our previous work , no specific link between oligo-anovulation and metabolic status was noticed in the PCOS group. It must be emphasized however that most of the women from this group were not severely obese, in contrast to other studies in different populations. As in our previous work (Dewailly et al., 2010) , PCA in PCOS patients yielded a PC (PC2) gathering relationships between variables that are well-known to define or to be associated with PCOS features (oligo-anovulation, TT, LH, AMH, 2-5 mm follicle number). This agrees with the hypothesis that the excess of AMH production and/or of 2-5 mm follicles, resulting from HA, is(are) involved in the follicular arrest of PCOS . However, contrary to our hypothesis, our data by PCA indicate that AMH is not directly implicated in the equilibrium between the 2-5 and 6-9 mm follicle numbers since it did not correlate to the 'equilibrium' PC. Likewise, androgens (represented by TT) did not correlate to this PC. This is consistent with the fact that their role on follicular growth lasts up to the stage of 2-5 mm follicles and then declines . In agreement, TT was strongly correlated to the 'follicular excess' PC, as previously reported (Dewailly et al., 2010) , but does not seem to play a direct role on the equilibrium between the 2-5 and 6-9 mm follicle pool. Last, serum FSH levels did not correlate to this PC. This is intriguing since slightly diminished FSH levels are indeed a common finding in PCOS women, as confirmed in the present study. This phenomenon seems to be linked to the 2-5 mm follicle number and serum AMH level as suggested by the negative relationships between FSH and these variables in our PCOS population (Table III) . However, these relationships were also observed in Controls (at least for AMH and just a trend for follicle number) (Table II) , which means that this phenomenon is not specific to PCOS. It is just amplified because of the follicle excess. This can explain that FSH did not correlate to the specific « PCOS » PC.
In the present study, no significant effect of age was observed in our PCOS patients, presumably because it was overwhelmed by factors causing the follicle excess. Conversely, in controls, age was strongly associated to the follicle status, as shown by its strong negative correlation to the PC called 'ovarian ageing' to which AMH and, to a lesser extent, 2-5 mm follicle number also correlated positively. However, no effect of age or AMH was found on follicle equilibrium in our control group. This disagrees with the data obtained in non PCOS women by Bentzen et al. (2013) in 2013 showing a specific link between age and follicle equilibrium, with a shift toward larger follicles with increasing age. However, it must be emphasized that our control population was younger. In Bentzen et al.'s (2013) work, 42% of the patients were between 35 and 42 years old while all our patients were under 35. To reconcile both findings, we suggest that age certainly plays a role in the equilibrium between 2-5 and 6-9 mm follicles but it is likely indirect, through the well-known age-related decrease of the 2-5 mm follicle number.
Indeed, the only variable specifically linked to the 6-9 mm follicle pool was the 2-5 mm follicle number, as shown by the presence of a unique PC representing specifically the equilibrium between these two follicle numbers. In our previous work (Dewailly et al., 2010) , this PC was not identified because we did not distinguish the 2-5 from the 6-9 mm follicle numbers in the follicle count. None of the other tested variables, mainly age in controls, androgens in PCOS and AMH in both groups had a direct relationship with this equilibrium, except a rather weak correlation of E2 in controls exclusively. Their influence appears to be indirect, through their interactions with the 2-5 mm follicle pool. Therefore, we suspect the presence of so-far unknown factor(s), regulating specifically the equilibrium between 2-5 and 6-9 mm follicles, whose influence would decrease with age in normal women and would be increased in PCOS women. Such factor(s) could be secreted by the oocytes which are known to affect the rate of initial recruitment from the primordial follicle pool into growing follicles (Vitt et al., 2000; Broekmans et al., 2009 ) and could also influence the equilibrium between the 2-5 and 6-9 mm follicles at the opposite end of the folliculogenesis process. Indeed, specific mutations or immunoneutralizations of bone morphogenetic protein Categorical variable: 0 if no ovulation disorder; 1 if oligoanovulation (defined as the presence of oligomenorrhe (i.e. fewer than eight menstrual bleeds over the previous year) or amenorrhoea (i.e. no menstrual bleed over the previous 3 months)).
15 (BMP15), BMP receptor B1 (BMPRB1) or growth differentiation factor 9 (GDF9) in ewes lead to multiple ovulations and dizygotic twinning (McNatty et al., 2005; Vinet et al., 2012; Juengel et al., 2013; Souza et al., 2014; Estienne et al., 2017) . This suggests that these oocyte factors are implicated in mono-ovulation control which could putatively have been exerted through the control of the equilibrium between the 2-5 and 6-9 mm follicular numbers. Interestingly, a deletion mutation in GDF9 has been found in sisters with spontaneous dizygotic twins (Montgomery et al., 2004; Vinet et al., 2012; Estienne et al., 2017) .
This study has numerous strengths. It is based on a large cohort of well characterized patients and we used a robust and sophisticated Table IV for controls and Table V for PCOS). The furthest spots from the reference line (in black) reflect the higher negative or positive correlations. For controls (A), PC1 (in blue) aggregated the 'metabolic variables'. PC2 (in yellow) reflected the equilibrium between the two follicle numbers ('follicle equilibrium'). PC3 (in green) was built on the strong inverse relationship between age and AMH ('follicle ageing'). Finally, PC4 (in violet) represented the positive correlation between FSH and LH ('gonadotropin regulation'). For PCOS (B), PC1 (in blue) aggregated the 'metabolic variables'. PC2 (in green) gathered the variables that are well-known to define or to be associated with follicular excess in PCOS (oligo-anovulation, TT, AMH, 2-5 mm follicle number). In PC3 (in yellow), the two follicle numbers were strongly and inversely correlated ('follicle equilibrium'). Finally, PC4 (in violet) represented the positive correlation between FSH and LH ('gonadotropin regulation'). statistical analysis. But it has some limitations: our controls did not represent the general population, we used a modified Rotterdam classification for PCOS using follicle count and/or serum AMH level with in-house thresholds to define the follicle excess and the AMH assay used is no longer commercially available.
In conclusion, we describe an independent negative correlation between the 2-5 and 6-9 mm follicle numbers. In PCOS women, this relationship is conserved and amplified, due to 2-5 mm follicular excess, but this does not seem to play a role in the follicular arrest leading to oligo-anovulation. None of the classical hormones implicated in the follicular growth (AMH, FSH, LH, E2, TT) and no parameter of the metabolic status (BMI, WC, Insulin) seem to be involved in this phenomenon. We hypothesize that the oocyte is involved in the equilibrium between both follicle numbers through factor(s) that still need to be identified. 
